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In an approach to study the evolutionary conservation of molecules of the Wnt signal transduction pathway, we analyzed the function of
the major negative regulator of this pathway, GSK3 (glycogen synthase kinase 3), in the basal metazoan Hydra. Microinjection assays reveal
that HyGSK3 inhibits h-catenin in zebrafish embryos, indicating that the function of GSK3 in the canonical Wnt signaling pathway is
evolutionarily conserved. In Hydra, HyGSK3 transcripts are strongly upregulated during gametogenesis. Treatment of female polyps with the
GSK3 inhibitors lithium and alsterpaullone prevents the differentiation of nurse cells and subsequent oocyte formation. Our data indicate that
GSK3 is required for the early induction of apoptosis in germline cells, which has been shown to be an initial step in Hydra gametogenesis.
Our experiments show that main functions of GSK3 are evolutionarily conserved and unique to multicellular animals, a conclusion which is
additionally supported by the presence of specific regulatory domains in the HyGSK3 protein.
D 2004 Elsevier Inc. All rights reserved.
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Glycogen synthase kinase 3 (GSK3) is an evolutionarily
conserved serine/threonine kinase involved in developmen-
tal processes in organisms ranging from Dictyostelium to
vertebrates (Ferkey and Kimelman, 2000; Frame and
Cohen, 2001). Originally, GSK3 was identified as a
negative regulator of glycogen synthesis, which is inacti-
vated upon insulin stimulation (Embi et al., 1980).
Subsequently, it has been shown that many of the devel-
opmental functions of GSK3 in metazoans are a conse-
quence of its role as a major negative regulator of the0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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(reviewed by Cadigan and Nusse, 1997). Secreted Wnt
molecules signal via Frizzled receptors and the cytoplasmic
protein Dishevelled to inactivate a complex of GSK3, Axin,
and the tumor suppressor Adenomatous polyposis coli
(APC). This inactivation prevents degradation of cytoplas-
mic h-catenin, which in the absence of Wnt signaling, is
continuously phosphorylated by GSK3 and thereby targeted
for proteolysis. Stabilized cytoplasmic h-catenin interacts
with transcription factors of the T-cell factor (Tcf) family
and regulates the expression of target genes (reviewed by
Seidensticker and Behrens, 2000).
The essential role of GSK3 in Wnt signaling and
development has been demonstrated by loss of function
studies in a variety of organisms. Expression of dominant
negative GSK3 constructs in Xenopus embryos induces
secondary axis formation (Dominguez et al., 1995; He et
al., 1995; Pierce and Kimelman, 1995); in sea urchin
embryos, it perturbs patterning of the animal–vegetal axisy 278 (2005) 1–12
F. Rentzsch et al. / Developmental Biology 278 (2005) 1–122(Emily-Fenouil et al., 1998; Wikramanayake et al., 1998).
Mutation of the Drosophila GSK3 homologue shaggy
(sgg) leads to disturbance of segment polarity and to
patterning defects in imaginal discs (Blair, 1994; Siegfried
et al., 1990). Even in the facultative multicellular slime
mold Dictyostelium, a GSK3 orthologue is involved in an
important developmental process: upon starvation-induced
aggregation, GSK3 controls cell fate choice between
prespore and prestalk cells (Ginsburg and Kimmel, 1997;
Harwood et al., 1995).
GSK3 has also been shown to act in other conserved
signal transduction pathways: in the Hedgehog pathway
GSK3 promotes proteolytic processing of the transcriptional
effector cubitus interruptus via phosphorylation and thereby
acts as a negative regulator similar to the situation in Wnt
signaling (Jia et al., 2002; Price and Kalderon, 2002). In
Notch signaling, GSK3 can act as a positive modulator
(Foltz et al., 2002; Ruel et al., 1999).
Of particular interest is the proapoptotic function of
GSK3. Inhibition of the phosphatidylinositol 3-kinase/Akt
cell survival pathway leads to activation of GSK3 and
increased apoptosis in neuronal cells and fibroblasts
(Hetman et al., 2000; Pap and Cooper, 1998). Proapoptotic
effects of GSK3 can also result from its role in Wnt
signaling (Chen et al., 2001). However, in the embryonic
mouse liver, GSK3h has an antiapoptotic function due to
regulation of NFnB signaling (Hoeflich et al., 2000). Thus,
GSK3 is a multifunctional enzyme, and although most of
its functions in early development are based on its role in
Wnt signaling, it is regulated by several inputs and
regulates for its part diverse targets in a context-dependent
manner.
In order to understand the evolutionary origin of the
molecular mechanisms that govern patterning processes in
metazoans, we recently isolated several components of
the canonical Wnt signal transduction pathway (HyWnt,
HyDsh, Hyh-catenin, HyTcf) from the freshwater polyp
Hydra and showed that Wnt signaling plays a major role
in axis formation in Hydra (Hobmayer et al., 1996,
2000). Hydra belongs to one of the earliest-diverging
metazoan phyla, the radially symmetric and diploblastic
cnidarians. The polyps mainly propagate asexually by
budding but are also capable of sexual reproduction. In
this study, we present evidence that the functions of
GSK3 in Wnt signaling and apoptosis are highly
conserved throughout metazoan evolution. Our character-
ization of a Hydra orthologue of GSK3 shows that
HyGSK3 can mimic the h-catenin-destabilizing function
of zebrafish GSK3 in microinjection assays. Transcripts
of HyGSK3 are detected uniformly along the body of
adult polyps and during head and foot regeneration.
During gametogenesis, HyGSK3 is strongly upregulated
in gamete-restricted interstitial cells. Using lithium and
alsterpaullone as GSK3 inhibitors, we find that HyGSK3
function is required for apoptosis of nurse cells, which is
an essential step in oocyte development. Since thestructure and expression of HyGSK3 are also consistent
with an involvement in glycogen metabolism, our results
indicate that GSK3 is a multifunctional protein already in
the basal metazoan Hydra.Materials and methods
Animals and culture conditions
As nonsexual polyps, the Hydra vulgaris strain Basel
was used; experiments on gametogenesis were carried out
with strain AEP (Martin et al., 1997). Maintenance of
mass cultures and induction of gametogenesis were done
as described before (Hobmayer et al., 2001).
Isolation and cloning of HyGSK3
Cloning of HyGSK3 by degenerate PCR and cDNA
library screening was done as described (Hobmayer et al.,
2000).
Zebrafish microinjection experiments
For RNA overexpression studies, the HyGSK3 open
reading frame was cloned into the pCS2 vector.
Analogues to the construct used by He et al. (1995), a
kinase dead HyGSK3 construct was made by replacing
Lys109 and Lys110 of the putative ATP binding pocket
by Arg via PCR mutagenesis (QuickChange Kit, Stra-
tagene, USA). After linearization with NotI, capped RNA
was synthesized using the sp6 MessageMachine kit
(Ambion, USA). Approximately 300 pg of RNA was
injected into one- to two-cell embryos. GFP RNA was
transcribed from pCS2/GFP with sp6 MessageMachine
Kit, and 75 pg per embryo was injected. Embryos were
kept at 28.58C under standard conditions (Westerfield,
1993).
In situ hybridizations
Whole-mount in situ hybridization was performed
with DIG-labeled RNA probes (Roche, Switzerland).
Hydra in situ hybridization was done as described by
Technau and Bode (1999). For color reactions, NBT/
BCiP (Roche) was used as substrate. Zebrafish in situ
hybridizations were done as described by Hammersch-
midt et al. (1996).
Lithium and alsterpaullone treatment
Wild-type and HyGSK3-injected zebrafish embryos at
the 32- to 64-cell stage were incubated in 0.3 M lithium
chloride for 15 min, washed twice, and kept in embryo
medium (Stachel et al., 1993). Sexually induced Hydra
polyps were incubated either from oogenesis stage 1/2 or
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medium containing 1 mM LiCl and 2.5 AM alsterpaullone
(Calbiochem), respectively. The medium was changed daily,
and the polyps were fed every third day with freshly hatched
Artemia nauplii.
Hydroxyurea (HU) treatment, acridine orange staining
In order to eliminate proliferating cells, polyps were
incubated with 10 mM hydroxyurea (Sigma). Effi-
ciency of the treatment was controlled by maceration
of polyps and counting of the different cell types
(David, 1973). The regimen for sexually induced
polyps was the same as for the lithium treatment:
polyps at oogenesis stages 1–2 were collected and
incubated in 10 mM hydroxyurea. For the detection of
apoptotic cells, live polyps were incubated in Hydra
medium containing 10 Ag/ml acridine orange (Sigma)
for 3 min, washed five times in Hydra medium. For
photography under fluorescent light, polyps were
relaxed in 1% heptanol. Animals were kept in the
dark during the staining procedure.Fig. 1. Sequence analysis of HyGSK3. Comparison of the (A) N-terminal region a
vulgaris GSK3 (GenBank accesion: AAG13665); human GSK3b (P49841);
Paracentrotus lividus (CAA10901); Dictyostelium discoideum (A55476). Alignme
background: semiconservative substitutions; filled square indicates N-termina
phosphorylation site; rhombuses indicate residues involved in substrate/pseudosu
additional conserved residues important for axin binding are located further towaResults
Structural and functional conservation of Hydra GSK3
Cloning of a GSK3 homologue from Hydra using
degenerate PCR and cDNA library screening has been
described previously (Hobmayer et al., 2000). The deduced
442 amino acid protein has a calculated molecular mass of
50 kDa; the catalytic domain comprising the central 289
amino acids has an identity of 80% compared to human
GSK3h (Fig. 1B).
HyGSK3 contains conserved residues that have been
shown to be of functional importance for activity and
regulation of the enzyme. Two lysine residues that are
indispensable for ATP-binding and kinase activity (He et al.,
1995) are located at amino acid positions 109 and 110.
Activity of GSK3 is enhanced by tyrosine phosphorylation
at a conserved position, which in HyGSK3 is present as
Tyr240 (triangle in Fig. 1B; Bhat et al., 2000; Hughes et al.,
1993; Wang et al., 1994).
HyGSK3 also meets the structural requirements for
regulation by insulin- and PI 3-kinase-like pathways.nd (B) catalytic domains of GSK3 molecules from different species. Hydra
human GSK3a (NP_063937); Drosophila melanogaster (CAA50212);
nts were done using ClustalW. Black background: consensus residues; gray
l inactivating phosphorylation site; filled triangle indicates activating
bstrate binding, asterisks indicate residues required for axin binding. Two
rds the C-terminus.
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substrate specificity of GSK3. Prephosphorylation of sub-
strates by another kinase facilitates their interaction with the
binding pocket of GSK3 and stepwise phosphorylation of
serine/threonine residues with a defined spacing (pSer/
ThrX3Ser/ThrX3Ser/ThrX3Ser/Thr). Insulin- or PI 3-kinase-
activated protein kinase B phosphorylates an N-terminal
serine of GSK3 which acts as a pseudosubstrate and blocks
the binding pocket of the same molecule (Dajani et al.,
2001; Stambolic and Woodgett, 1994; ter Haar et al., 2001).
HyGSK3 contains all residues required for this mode of
regulation: the N-terminus comprises a well-conserved
pseudosubstrate region with Thr34 as phosphorylation site
(Fig. 1A); the positively charged residues of the binding
pocket that can bind the primed substrate/pseudosubstrate
are Arg120, Arg204, and Lys229 (rhombuses in Fig. 1B).
GSK3 is also inhibited in cells receiving Wnt signals
(Cook et al., 1996; Ruel et al., 1999). The exact molecular
mechanism of Wnt-induced GSK3 inhibition is still unclear.
The prevailing model suggests that Wnt signaling results in
the disassembly of the h-catenin destruction complex. In
this complex, axin acts as a scaffold to bring GSK3, APC,
and h-catenin into close proximity, thereby facilitatingFig. 2. Microinjection experiments in zebrafish embryos. (A) Uninjected embryo
300 pg) at 32 hpf, arrow marks expanded, faintly red blood islands, indicative o
at the enlarged yolk extension; (C–G) animal pole view of in situ hybridizatio
embryo injected with HyGSK3 RNA; (E) embryo injected with kinase dead H
marked by goosecoid expression; (F) lithium-treated embryo; (G) HyGSK3 RN
lithium, indicating that it is inhibited by lithium; (H, I) fluorescence photogr
sphere stage. Lithium treatment does not lead to reduced fluorescence signal,phosphorylation of h-catenin by GSK3. This ultimately
results in degradation of cytoplasmic h-catenin (Ding et al.,
2000; Fraser et al., 2002; Li et al., 1999). In HyGSK3, 27 of
29 amino acids that influence binding of human GSK3h to
axin are conserved, suggesting that the structural require-
ments for an analogous regulatory interaction are present in
HyGSK3 (asterisks in Fig. 1B; Dajani et al., 2003; Fraser et
al., 2002). Thus, the primary structure of HyGSK3 is in
agreement with a function in pathways analogous to insulin,
PI 3-kinase, and Wnt signaling in vertebrates.
In order to test functional conservation of HyGSK3 as a
regulator of h-catenin, we injected HyGSK3 RNA into one-
to two-cell zebrafish embryos. HyGSK3 injection mimicked
the ventralizing effect of zebrafish GSK3, leading to an
expansion of blood islands (arrows in Figs. 2A, B), the
ventralmost mesoderm derivative, and a slightly enlarged
ventral tailfin tissue (Figs. 2A, B; Nasevicius et al., 1998).
HyGSK3-injected embryos additionally display two features
frequently observed upon ventralization: an expanded
posterior yolk extension (arrowhead in Figs. 2A, B) and a
downward bending of the tail (Kishimoto et al., 1997). To
confirm that the observed phenotypes are caused by early
patterning defects, we used goosecoid as a marker for theat 32 h post fertilization (hpf); (B) HyGSK3 RNA-injected embryo (ca.
f ventralization; also note the reduced size of the eyes, arrowhead points
ns with goosecoid at shield stage; (C) control embryo, dorsal right; (D)
yGSK3, arrows in C–E indicate the width of the embryonic shield as
A-injected + lithium. HyGSK3 does not prevent dorsalization caused by
aphy of untreated (H) and lithium-treated (I), GFP-injected embryos at
indicating that protein synthesis is not disturbed.
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with the phenotypic ventralization, injection of HyGSK3
RNA reduced the size of the shield (Figs. 2C, D). In
contrast, a HyGSK3 version in which the ATP binding site is
destroyed and which has previously been used as a
dominant negative construct (He et al., 1995; Nasevicius
et al., 1998) caused an expansion of the goosecoid positive
shield (Figs. 2C, E). These experiments show that the high
structural conservation of HyGSK3 correlates with func-
tional conservation in the context of regulation of canonical
Wnt signaling.
Lithium has been shown to inhibit GSK3 activity in
organisms ranging from Dictyostelium to mammals (Klein
and Melton, 1996; Phiel and Klein, 2001). Treatment of
zebrafish embryos with lithium during early development
leads to an expansion of the shield into lateral and ventral
regions as visualized during gastrulation by in situ hybrid-
ization with goosecoid. (Fig. 2F, Stachel et al., 1993). To
determine whether lithium also inhibits HyGSK3, we
treated HyGSK3-injected embryos with lithium. Injection
of HyGSK3 could not attenuate the expansion of the
organizer by lithium, indicating that lithium acts as an
inhibitor of HyGSK3 (Fig. 2G). Lithium did not reduce the
translation of coinjected GFP RNA derived from the same
expression vector (Figs. 2H, I), indicating that the failure of
HyGSK3 RNA to rescue the lithium effect is not due toFig. 3. Expression of HyGSK3 during spermatogenesis. In situ hybridization shows
polyp lacking proper testes and GSK3 expression, (D) higher magnification of imimpaired protein synthesis but rather due to inhibition of
HyGSK3 protein. Additional support for this conclusion
comes from the finding that lithium can inhibit HyGSK3
activity in Hydra cell extracts (B. Reinhardt and H. Bode,
personal communication). It should be noted that lithium
can have complex effects on Hydra and may also affect
other proteins (Hassel and Bieller, 1996).
HyGSK3 is upregulated during gametogenesis
In situ hybridization experiments revealed a uniform
level of HyGSK3 transcripts in epithelial cells along the
entire body column except the foot region, which was
devoid of any transcripts (Fig. 3A). No transcriptional
alteration of HyGSK3 occurred during regeneration (data
not shown). Expression analysis of fractionated cell types
(Greber et al., 1992) from asexually reproducing Hydra
polyps confirmed that HyGSK3 is mainly expressed in
epithelial cells (data not shown). However, in contrast to the
uniform expression in asexually reproducing polyps, tran-
scription of HyGSK3 was strongly upregulated during
gametogenesis.
Oogenesis commences with an aggregation of egg-
restricted interstitial stem cells (I cells) in the ectoderm of
the upper region of the body column. The egg-restricted I
cells first divide into clusters which finally fuse to form a(A) adult polyp, (B) male polyp with mature testes, (C) hydroxyurea-treated
mature and (E) mature testis.
F. Rentzsch et al. / Developmental Biology 278 (2005) 1–126single large aggregation. During this process, the cell cycle
accelerates from ca. 72–90 to ca. 24 h (Holstein and David,
1990; Miller et al., 2000). As one of the aggregated
interstitial cells in the center of the egg field is selected to
become the oocyte, the remaining interstitial cells stop to
proliferate and begin to differentiate into nurse cells which
subsequently enter an apoptotic program and become
phagocytosed by the growing oocyte. The differentiation
process starts in the center of the egg field and progresses
radially. Several thousand interstitial cells are finally
incorporated in the oocyte (Honegger et al., 1989; Miller
et al., 2000; Tardent, 1978).
Upregulation of HyGSK3 becomes visible from the
earliest stages of aggregation in clusters of only eight cells
(Fig. 4A). The size and the rounded morphology of these
clustered cells identify them as egg-restricted interstitial
cells (Honegger et al., 1989; Miller et al., 2000; Technau et
al., 2003). Upregulation is maintained until the accumu-
lation of interstitial cells has reached its maximum. After the
oocyte is selected, the level of transcription decreases in a
concentric wave starting around the center of the egg field.
Finally, uniform levels of transcripts along the body column
and within the large oocyte are restored (Figs. 4B–E).
To exclude the possibility that transcriptional upregula-
tion in gamete-restricted I cells is a general, nonspecific
phenomenon, we performed in situ hybridization with a
Hydra elongation factor 1a (EF1a) probe. The expressionFig. 4. Expression of HyGSK3 during oogenesis. (A) Close-up of small clusters of
and (E) stage 6 exhibit a diminished GSK3 expression; (F) hydroxurea-treated poly
according to Miller et al. (2000).of EF1a in female polyps was uniform at all stages of
oogenesis (data not shown).
We also analyzed GSK3 expression during spermato-
genesis. During early spermatogenesis, sperm-restricted I
cells rather form strings than circular patches (Littlefield et
al., 1991; Nishimiya-Fujisawa and Sugiyama, 1993). By an
aggregation of these sperm-restricted cells, mature testes are
gradually formed. A male polyp can build up to 10 testes.
Spermatogonia and spermatocytes are located at the basal
part of the testis, and differentiating spermatids and
spermatozoa are released to the distal part, which is covered
by the ectodermal epithelium (Kuznetsov et al., 2001;
Tardent, 1974). Similar to oogenesis, the cell cycle of
spermatogonia rapidly accelerates as they reach a size of
16–32 cells (Littlefield et al., 1991). We could not detect any
upregulation of HyGSK3 transcripts during early stages of
spermatogenesis. Only at later stages, we found a strong
upregulation in the basal parts of the testes (Figs. 3B, D–E).
The dynamic pattern of HyGSK3 upregulation during
oogenesis and spermatogenesis could be correlated either to
cell cycle acceleration of gametes (Holstein and David,
1990; Littlefield et al., 1991; Miller and Steele, 2000;
Munck and David, 1985) or to apoptosis. To test whether a
transcriptional upregulation of HyGSK3 is correlated to an
acceleration of the cell cycle in fast-proliferating germline
cells, we treated male and female animals with hydroxyurea
(HU). HU blocks progression through S-phase and inducesegg-restricted interstitial, (B) oogenesis stage 2; (C) stages 3–4; (D) stage 5,
p at stage 3 exhibiting a similar expression level as control animals. Staging
Fig. 6. Effect of lithium on nurse cell differentiation. (a, c, e) Live animals;
(b, d, f) acridin orange stainings; (a, b) untreated animals at stage 5; (c), (d)
untreated animals at stage 7 (mature oocyte); (e, f) lithium-treated polyps.
Note the reduced number of apoptotic nurse cells after lithium treatment.
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Thus, all fast-cycling cells can be selectively removed from
Hydra tissue by temporally restricted HU treatment.
Treatment of asexual polyps with 10 mM HU for 5 days
resulted in an almost complete loss of all interstitial cells
(data not shown). In HU-treated male polyps, we found that
proliferating spermatogonia and their progeny were elimi-
nated, and the upregulation of GSK3 at the basis of the
testes disappeared (Fig. 3C). However, in female polyps
treated with HU from oogenesis stages 1–2, we found a
persistent upregulation of HyGSK3 in clusters of egg-
restricted I cells and in later stages of oogenesis, which was
similar to untreated animals (Fig. 4F). This indicates that the
upregulation of HyGSK3 during oogenesis is maintained,
even after proliferation of egg-restricted I cells has ceased.
In accord with this finding, we also found elevated levels of
GSK3 transcripts in very early and small clusters of egg-
restricted I cells (Fig. 4A); such cells have a slow cell cycle
(Holstein and David, 1990; Littlefield et al., 1991). We
therefore conclude that transcriptional upregulation of
HyGSK3 during gametogenesis is not correlated with the
length of the cell cycle or with cell cycle alterations.
The GSK3 inhibitor lithium interferes with oocyte formation
To obtain further evidence for the physiological rele-
vance of HyGSK3 function during oogenesis, we treated
female polyps with lithium chloride, a potent inhibitor of
GSK3. Lithium treatment (1 mM) caused severe defects in
oocyte development when polyps were treated from the
beginning of oogenesis (stages 1–2). After 5 days of lithium
treatment, only 2.5% of the polyps had formed an oocyte
(n = 135) in contrast to 78% (n = 106) of the control animals
(Fig. 5). Treatment with a second GSK3 inhibitor, alster-
paullone (Knockaert et al., 2002; Leost et al., 2000), had aFig. 5. Effect of lithium on Hydra oogenesis. Animals were selected at
stages 1–2 of oogenesis. Within 7 days, 78% F 12% of control animals had
formed an oocyte (n = 106, four independent experiments), lithium
treatment (1 mM) from stages 1–2 reduced the percentage to 2.5% F 2.9%
(n = 135, four independent experiments), while lithium treatment from
stages 3–4 resulted in 64% F 11% polyps forming oocytes (n = 35, two
independent experiments).
All photographs are of different specimens.similar effect as lithium (7.6% oocytes after treatment with
2.5 AM alsterpaullone at stages 1–2, n = 67), indicating that
the observed phenotypes are indeed due to inhibition of
HyGSK3 activity. While regular oocyte formation is
characterized by the formation of typical finger-like
pseudopodia which engulf the body column and mediate
the incorporation of apoptotic nurse cells into the growing
oocyte (Figs. 6a,c), in LiCl-treated animals, such an
accumulation was never found; instead, the accumulation
of nurse cells was incomplete and appeared unstructured
and bulky, so that normal oocytes could not form (Fig. 6e).
Only in rare cases we observed the formation of multiple
very small boocyte-likeQ structures, which remained in the
ectoderm. Even after 5 days of lithium treatment, the egg-
restricted interstitial cells still did strongly express the
HyGSK3 message, whereas in untreated animals GSK3
expression was already downregulated, indicating that they
were unable to progress properly through oogenesis (data
not shown). However, the phenotype caused by lithium
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oogenesis, ruling out the possibility that lithium only delays
oocyte development.
When lithium treatment was started at later stages of
oocyte differentiation, when the oocyte had already started
to form (stages 3–4), a much weaker inhibition of oogenesis
was observed (Fig. 5; 64% oocytes, n = 35). This indicates
that lithium affects primarily early stages of oogenesis,
when HyGSK3 transcripts are also strongly upregulated.
Since oocyte formation was also insensitive to HU treatment
(see above), it is rather unlikely that the inhibitory effect of
lithium was due to a block of cell cycle. More likely, it could
be related to the generation of nurse cells and probably to
nurse cell apoptosis, which has been found to be a major
step during oogenesis (Technau et al., 2003).
The first visible sign of nurse cell differentiation is an
accumulation of nutritive substances such as lipids, glyco-
gen, and yolk-like material. Transfer of cytoplasmic frag-
ments into the oocyte leads to shrinkage of the nurse cells
which finally display ultrastructural characteristics of
apoptotic cells and become phagocytosed by the oocyte
(Honegger et al., 1989). However, nurse cell apoptosis
remains incomplete since DNA fragmentation, which is
typical of late stage apoptosis, cannot be detected by DAPI
or TUNEL staining (Technau et al., 2003). Detection of
apoptotic cells with acridine orange (AO) also shows
differences between apoptosis of nurse cells and HU-treated
interstitial cells. Apoptotic nurse cells have a bright green,
often crescent-shaped labeling, whereas HU-induced apop-
tosis results in intense orange staining of the whole,
condensed but still spherical cell (Miller et al., 2000).
We used AO staining to investigate whether lithium
treatment disturbs the differentiation program of nurse cells.
In control animals, all nurse cells incorporated into the
growing and finally in the mature oocyte are labeled by AO
(Figs. 6b, d). In contrast, treatment of female polyps with
lithium resulted in a strong reduction of the number of AO-
stained cells (Fig. 6f). Interestingly, the size of the egg field
in these lithium-treated animals remained unchanged
compared to untreated control animals. This indicates that
treatment with the GSK3 inhibitor lithium chloride reduced
only the number of apoptotic nurse cells (AO-positive cells),
but not the total number of nurse cells which continue to
accumulate in the egg field. Thus, HyGSK3 is required for
the initiation of nurse cell apoptosis during oogenesis.Discussion
GSK3 regulates various cellular processes in Wnt-
dependent and -independent contexts. We isolated a GSK3
orthologue from the basal metazoan Hydra (HyGSK3) and
characterized its potential functions in developmental
situations. Database searches and protein alignments
revealed an overall amino acid identity of 70% compared
to human GSK3h and of 80% within the catalytic domain.This clearly classifies the deduced protein as a member of
the GSK3 family of serine/threonine kinases. Since also
other structural motives of GSK3 are highly conserved in
Hydra, we presume that multiple functions of this enzyme
arose already early in evolution.
GSK3 has multiple functions in Hydra
GSK3 has a conserved function as a negative regulator of
the canonical Wnt signal transduction pathway. Wnt signal-
ing inhibits GSK3 via a complex change in the interactions
of a multiprotein complex. Several findings indicate that
HyGSK3 has a homologous function in Hydra. First, the
high overall conservation of the catalytic domain (80%
identity to human GSK3) and specifically the presence of 27
of 29 residues important for binding to the scaffolding
protein axin (Dajani et al., 2003; Fraser et al., 2002) provide
the structural basis for a conserved role in Wnt signaling.
Second, Hyh-catenin contains a consensus GSK3 phosphor-
ylation site in its N-terminus, making it a possible substrate
for HyGSK3. Third, the ventralizing activity of HyGSK3 in
zebrafish embryos shows its ability to regulate h-catenin in
this heterologues situation. Finally, Wnt signaling has been
proposed to be active in the Hydra head organizer
(Hobmayer et al., 2000), and the GSK3 inhibitor lithium
augments the activity of the head organizer (Broun and
Bode, 2002), consistent with a role of HyGSK3 as a
negative regulator of Hydra Wnt signaling.
GSK3 can also be inhibited by insulin via PKB-mediated
phosphorylation of an N-terminal serine residue (Ser9 in
GSK3h). The phosphorylated serine serves as a pseudosub-
strate that blocks the binding pocket of the enzyme (Dajani
et al., 2001; ter Haar et al., 2001). Although the serine is
changed to a functionally conserved threonine in HyGSK3,
the primary structure of this region makes it a good
candidate for regulation by a conserved mechanism (Cook
et al., 1996). Homologues of an insulin receptor and PKB
have been cloned from Hydra, and insulin affects DNA
synthesis and cell proliferation in polyps (Herold et al.,
2002; Steele et al., 1996). Since both genes are uniformly
expressed along the body column, the epithelial expression
of HyGSK3 might be related to its function in insulin-
regulated glycogen metabolism, similar to the situation in
vertebrates. It should also be noted that the N-terminal
phosphorylation site is not found in GSK3-like proteins
from unicellular organisms and plants, which may indicate
that the pseudosubstrate regulatory mechanism is linked to
intercellular signaling pathways employed only by multi-
cellular animals.
A further, so far less well-understood function of GSK3
is its role in apoptosis and gametogenesis (see below).
A proapoptotic function of GSK3 in Hydra gametogenesis
The surprising finding of this study was thatHyGSK3 was
significantly upregulated during Hydra gametogenesis (see
Fig. 7. Summary of GSK3 expression and apoptosis in Hydra gametogenesis. Schematic drawing and staging of key steps in oogenesis and gametogenesis.
Female and male restricted interstitial cells are drawn in white, intact nurse cells in light gray and apoptotic nurse cells in dark gray. The oocyte and polar
bodies are indicated red, while spermatogonia, spermatocytes, spermatids, and sperms in blue. GSK3 expression starts early during oogenesis (stages 1–2)
which correlates with the LiCl-sensitive phase of oogenesis, and ceases when pseudopodia retract (stage 5); first acridine orange-positive, apoptotic stages (not
shown) arise at the onset of nurse cell growth, and they remain in phagocytosed cells until end of embryogenesis (due to an arrest in apoptosis; for details, see
Technau et al., 2003). During spermatogenesis, GSK3 expression starts late, and it is restricted to the base of testes. Scheme modified (Holstein, 1994; Miller et
al., 2000).
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oogenesis and spermatogenesis). During testes development,
the upregulation was only observed at a late stage after the
accumulation of the sperm-restricted I cells into testes. Since
we analyzed large numbers of polyps at different times after
sex induction, we consider it to be unlikely that we missed
early stages of spermatogenesis expressing GSK3. At later
stages of spermatogenesis, the upregulation is confined to the
basis of the testes, a region that contains predominantly
spermatogonia and spermatocytes (Kuznetsov et al., 2001).
Interestingly, strong acridine orange staining has been
detected in the whole testis, indicating that apoptosis is
involved in spermatogenesis (Kuznetsov et al., 2001).
During oogenesis, the upregulation of HyGSK3 is also
limited to the gamete-restricted I cells, but here it precedes
cell cycle acceleration. In contrast to testis development,removal of fast-cycling cells by prolonged hydroxyurea
treatment failed to eliminate the upregulating cells during
oogenesis. This shows that the elevated expression level is
also maintained after the end of proliferation.
Comparison of the expression pattern of HyGSK3 with
that of the receptor tyrosine kinase lemon further indicates
that the upregulation of HyGSK3 is not generally correlated
with an accelerated cell cycle. The expression pattern of
lemon during gametogenesis resembles that of HyGSK3, but
HU treatment removes all lemon-upregulating interstitial
cells showing that the upregulation is restricted to fast-
proliferating germ cells. It should be pointed out that
expression levels of lemon also reflect the cell cycle length
of interstitial cells in nonsexual polyps (Miller, 1999; Miller
and Steele, 2000). Although HyGSK3 is expressed in all cell
types, we could not detect transcriptional upregulation in
F. Rentzsch et al. / Developmental Biology 278 (2005) 1–1210interstitial cells of nonsexual polyps. Functional evidence
for a role of HyGSK3 in a process different from
proliferation comes from the distinct effects of HU and
lithium treatment. While HU treatment had little effect on
the completion of oogenesis, lithium treatment at the same
stages strongly inhibited oogenesis. Therefore, it is unlikely
that the upregulation of HyGSK3 during oogenesis is cell
cycle-related (see below).
Two major steps can be distinguished during nurse cell
differentiation in Hydra: first, the cells accumulate nutritive
substances like lipids and glycogen, later they enter an
apoptotic program, which undergoes an arrest during the
maturation of the oocyte. This arrest is only relieved after
hatching of the primary polyps (Honegger et al., 1989;
Miller et al., 2000). Only in the hatching embryo the
apoptotic program is completed (Technau et al., 2003). In
female polyps treated from stages 1–2 with the GSK3
inhibitor lithium, nurse cells fail to enter the apoptotic
program, as shown by the absence of acridine orange
staining. In contrast, lithium treatment started at stages 3–4
and, thus after the nurse cells have entered the apoptotic
program (Honegger et al., 1989; Technau et al., 2003), only
has a mild effect on the completion of oogenesis.
Perturbation of each of the two differentiation steps could
prevent entry into apoptosis, either indirectly or directly.
However, since accumulation of glycogen in higher
metazoans requires inhibition of GSK3, we consider it
unlikely that the upregulation of HyGSK3 is related to this
process during nurse cell differentiation.
It has recently been shown that GSK3 has a proapoptotic
function in mammalian cells (Hetman et al., 2000; Pap and
Cooper, 1998). In analogy, HyGSK3 could be required
directly for the entry of differentiated nurse cells into the
apoptotic program in response to a signal from the
determined oocyte (Miller et al., 2000). Interestingly,
treatment of female polyps with caspase inhibitors causes
phenotypes very similar to those caused by lithium. More-
over, lithium as well as caspase inhibitors interfere with
oogenesis only when applied at early stages of oocyte
development (Technau et al., 2003), and GSK3 can activate
caspase 3 (Song et al., 2002). Together, these results suggest
that HyGSK3 has a conserved proapoptotic function in
nurse cell differentiation and gametogenesis.
Regulation of GSK3 activity during Hydra gametogenesis
It appears paradox that HyGSK3 should be inhibited to
promote the accumulation of glycogen but activated to drive
nurse cells into apoptosis at the same time. A possible
explanation comes from experiments that have shown that
different GSK3-regulating signals affect only pathway-
specific targets of GSK3 (Culbert et al., 2001; Ding et al.,
2000). This has led to the conclusion that GSK3 is
sequestered in different multiprotein complexes that link
signals to specific GSK3 substrates, thereby allowing
different effects on different substrates at the same time.During Hydra oogenesis, it is yet unclear which signals
regulate HyGSK3 activity. Although we were unable to
detect expression of HyWnt, which is a homologue of Wnt3a
(Kusserow, Hobmayer, and Holstein, unpublished results), at
any stage of oogenesis, it is possible that additional, yet
unidentified Wnt’s are involved in this process. This idea is
supported by the identification of a number of Wnt genes in
the basal cnidarian Nematostella vectensis (Kusserow,
Hobmayer, and Holstein, unpublished results).
GSK3 in Hydra gametogenesis could also be part of the
regulatory network of Notch signaling. In Drosophila,
Notch signaling regulates the process of lateral inhibition
by which a single neuronal cell becomes determined from a
field of equivalent precursor cells (Artavanis-Tsakonas et
al., 1999). Selection of the oocyte in Hydra involves a
similar process (Miller et al., 2000). Since GSK3 can affect
Notch signaling (Foltz et al., 2002; Ruel et al., 1999) and
components of this pathway have been isolated from Hydra
(Steele, 2002), it will be interesting to determine the role of
this pathway during Hydra oogenesis. Alternatively, acti-
vation of HyGSK3 might be a secondary response to an
external signal. In this scenario, HyGSK3 would be
involved directly in an initial step of the execution of the
apoptotic program of nurse cells, for example, by mod-
ification of the cytoskeleton or by posttranslational activa-
tion of proapoptotic enzymes (Goold et al., 1999; Krylova et
al., 2000; Song et al., 2002).
In conclusion, we show that activity of HyGSK3 is
required for oogenesis, presumably due to a proapoptotic
function in nurse cell differentiation. Additionally, structure
and expression of the molecule support the idea that HyGSK3
acts in Wnt- and insulin-like pathways and thus is a
multifunctional protein already in the basal metazoan Hydra.Acknowledgments
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